EKB-569

EKB-569 · Wyeth Pharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for EKB-569, covering 2009-08-21 to 2013-06-04. Get the full timeline:

Most recent: Clinical Trial Update: CCI-779 and EKB-569 in Treating Patients With Advanced Solid Tumors [Phase 1]